| Name | Title | Contact Details |
|---|---|---|
Johnathan Van Meter |
Senior Director, Human Resources | Profile |
Ruby Hofmann |
Vice President of Human Resources and Organizational Development | Profile |
Ruby Hofmann |
Senior Vice President of Human Resources and Organizational Development | Profile |
Biocentric Solutions, Inc. is a Madison, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Clinical Data, Inc. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Discovery Genomics, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
OvaScience (NASDAQ: OVAS) is a global fertility company dedicated to improving treatment options for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments because we believe women deserve more options. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPCSM) cells – immature egg cells found inside the protective ovarian lining.
Triplet Therapeutics is a biotechnology company developing transformational treatments for patients with repeat expansion disorders (REDs) -- a group of more than 50 known genetic diseases including Huntington`s disease, myotonic dystrophy, spinocerebellar ataxias, fragile X syndrome, and familial amyotrophic lateral sclerosis (ALS) -- leveraging insights from patient genetics. Triplet designs and develops potential therapeutics for REDs using its proprietary thRED Engine, which enables the Company to develop a single oligonucleotide targeting the DNA Damage Response (DDR) pathway to potentially treat multiple REDs. Triplet is backed by investments from Atlas Venture, MPM Capital and Pfizer Ventures, along with Invus, Partners Innovation Fund and Alexandria Venture Investments.